Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

50 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

NCT00678392

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • East Valley Hematology and Oncology Medical Group Burbank, California, United States
  • Maurice Berkowtiz, MD Burbank, California, United States
  • Agajanian Institute of Oncology and Hematology Downey, California, United States
  • Los Angeles Hematology/Oncology Medical Group Glendale, California, United States
View all 294 locations
View Trial Details
Completed

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

NCT00375674

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • Ronald Reagan UCLA Medical Center Department of Pharmaceutical Services Los Angeles, California, United States
  • UCLA Clark Urology Center Los Angeles, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • The Emory Clinic, Inc Atlanta, Georgia, United States
View all 115 locations
View Trial Details
Completed

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

NCT00065468

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site La Verne, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site San Diego, California, United States
View all 153 locations
View Trial Details
Completed

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

NCT00282048

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site The Bronx, New York, United States
  • Pfizer Investigational Site Cleveland, Ohio, United States
  • Pfizer Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

NCT00076011

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • Pfizer Investigational Site San Francisco, California, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site New York, United States
View Trial Details
Completed

EPO906 Therapy in Patients With Advanced Kidney Cancer

NCT00035243

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Maryland Baltimore, Maryland, United States
  • Wayne State University Karmanos Cancer Center Detroit, Michigan, United States
  • Our Lady Of Mercy Medical Center The Bronx, New York, United States
View Trial Details
Completed

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

NCT00101608

Conditions
Bladder Cancer, Bladder Neoplasms, Carcinoma, +21 more
Locations
  • Local Institution Beverly Hills, California, United States
  • Local Institution La Jolla, California, United States
  • Local Institution Los Angeles, California, United States
  • Local Institution Santa Monica, California, United States
View all 75 locations
View Trial Details

Related conditions